Core Laboratories NV CLB reports Q2 EPS $0.71 vs consensus of $0.72. Core Laboratories NV reports Q2 revenue $198.9 million vs consensus of $189.52 million.
The company said that they see Q3 EPS of $0.76 to $0.78. This compares to the Street consensus of $0.76 per share on revenue of 197.11 million.
Shares of CLB are bid lower in the after-hours.
Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The company operates in three business segments: reservoir description, production enhancement and reservoir management.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in